Reader Study Spreadsheet Sequential Studies
Study (First Author)	# Patients	# Readers	# Cancers	# Patients Recalled WITHOUT CAD	# Patients Recalled WITH CAD	# Masses detected WITHOUT CAD	# Masses detected WITH CAD	# Calcs detected WITHOUT CAD	# Calcs detected WITH CAD	# of Additional CAD detected Calc cases that were DCIS	Stat Significant change sensitivity	Standalone CAD Sensitivity Masses	Standalone CAD Sensitivity Calcs	FP Marks per patient
Freer	12,860	2	49	830	986	26	27	15	22	6	NO	67%	100%	2.8
Helvie*	2389	13	11	344	378	7	7	3	4	1	NO	83%	100%
Birdwell	8682	7	29			15	17	12	12	0	NO	71%	92%	2
Morton	21,349	12	105	2101	2300	79†	82	26	31	5	NO	67%	100%	2.8
Dean**	5631	1	35											3.2
Ko	5016	2	48^	602	702	27	27	16	18	2	NO	67%	100%	4
* Non-Commercial CAD Device
^ 3 cancers were deteced at one year followup
†9 of 10 cases of architectural distortion were detected without CAD and are included in the mass totals
** The Dean study included both screening and diagnostic patients.  The data was not all clearly reported separate for the two groups.
Dean noted that the four additional cancers in the screening group detected by CAD were marked by Calcification marks and two were DCIS.